The South African Prostate Cancer Screening Guidelines by J John, A Adam, L Kaestner, P Spies, S Mutambirwa, J Lazarus

“… Prostate cancer (PCa) is the most widespread solid organ malignancy in males and ranks as the fifth leading cause of death globally. …”
Get full text

Prostate cancer perspective: Africa versus the world by B Marais, G Klopper, J John

“… Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men, with a rising global incidence. …”
Get full text

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review by Goran Bencina, Elina Petrova, Demet Sönmez, Sonia Matos Pereira, Ioannis Dimitriadis, Stina Salomonsson

“…Recently, novel therapies have received regulatory approval with significant improvement in overall survival for metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, and nonmetastatic castration-resistant prostate cancer. …”
Get full text

Association between magnesium depletion score and prostate cancer by Hongyang Gong, Xiaomei Lin, Shaoqun Huang

Subjects: “…Prostate cancer…”
Get full text

<i>Lady urologist</i> and male patients with prostate cancer by Rodolfo Montironi, Antonio Lopez-Beltran, Meredith C. Wasserman, Alessia Cimadamore, Liang Cheng

Get full text

Racial Disparities and Mental Health Effects Within Prostate Cancer by Kaylynn J. Conant, Hanh N. Huynh, Jolene Chan, John Le, Matthew J. Yee, Danyon J. Anderson, Alan D. Kaye, Benjamin C. Miller, Joseph D. Drinkard, Elyse M. Cornett, Alexander Gomelsky, Ivan Urits

“…Disparities in prostate cancer (PCa) exist at all stages: screening, diagnosis, treatment, outcomes, and mortality. …”
Get full text

Insights into prostate cancer awareness and perceptions among men in Tshwane by L Nzombe, J Shirinde, S Patrick

Subjects: “…Prostate Cancer…”
Get full text

Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer by I. S. Ignatov, V. V. Balaban, E. A. Bezrukov, A. V. Nikishina, M. He, P. V. Tsarkov

Subjects: Get full text

LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p by Yongsheng Yu, Nan He, Zhaolu Song, Chang Wang, Jinhuang Xu

Subjects: “…Prostate cancer…”
Get full text

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer by Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, Tunc Morova, Chia-Chi Flora Huang, Betul Ersoy Fazlioglu, Ivan Pak Lok Yu, Batuhan M. Kalkan, Paloma Cejas, Sonia H. Y. Kung, Ladan Fazli, Akane Kawamura, Henry W. Long, Ceyda Acilan, Tamer T. Onder, Tugba Bagci-Onder, James T. Lynch, Nathan A. Lack

“…Abstract Enzalutamide is a potent second-generation antiandrogen commonly used to treat hormone-sensitive and castration-resistant prostate cancer (CRPC) patients. While initially effective, the disease almost always develops resistance. …”
Get full text

Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers by Hua Huang, Huibo Lian, Wang Liu, Benyi Li, Runzhi Zhu, Haiyan Shao

Subjects: “…Prostate cancer…”
Get full text

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance by Caihong Li, Dongkai Cheng, Peng Li

Subjects: “…prostate cancer…”
Get full text

Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review by Angela Patricia Salinas Pita, Mildrey Mosquera Escudero, Eliecer Jiménez-Charris, Herney Andrés García-Perdomo

Subjects: Get full text

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population by Indrawarman Soerohardjo, Narpati Wesa Pikatan, Andy Zulfiqqar, Irianiwati Widodo, Didik Setyo Heriyanto

Subjects: “…Castration-resistant prostate cancer…”
Get full text

Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives by Hubo Yang, Xuefeng Zhang, Zongming Jia, He Wang, Jixiang Wu, Xuedong Wei, Yuhua Huang, Wenying Yan, Yuxin Lin

Subjects: “…Prostate cancer…”
Get full text

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer by Yuxuan Chen, Haisheng Yan, Yaoqin Xu, Kexin Chen, Runqin Yang, Jiali Yang, Ruian Zhu, Rui Lin, Jiang Wang, Jie Liu, Pingsheng Gao, Lei Pang, Lexin Wang

Subjects: “…Prostate cancer…”
Get full text

Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel by Keith L. Davis, Benjamin Gutierrez, Teresa Zyczynski, James A. Kaye

“…**Background:** Docetaxel has been a standard of care for castration-resistant prostate cancer (CRPC) in the United States since 2004, yet little has been reported on its patterns of use in routine practice. …”
Get full text

BioLake: an RNA expression analysis framework for prostate cancer biomarker powered by data lakehouse by Qiaowang Li, Yaser Gamallat, Jon George Rokne, Tarek A. Bismar, Reda Alhajj

Subjects: Get full text

Correction: Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer by Minmin Lan, Lianhua Zhu, Yixuan Wang, Daijia Shen, Kejing Fang, Yu Liu, Yanli Peng, Bin Qiao, Yanli Guo

Get full text

Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer by Yankui Liu, Anjie Chen, Yufan Wu, Jiang Ni, Rong Wang, Yong Mao, Ning Sun, Yuanyuan Mi

“…Abstract We here investigate the expression of the mitochondrial carrier homolog 2 (MTCH2) and its potential function in castration-resistant prostate cancer (CRPC). Bioinformatic analyses reveal that MTCH2 overexpression is associated with critical clinical parameters of prostate cancer. …”
Get full text